Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ, Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12), Neurology 60 (2003), 31-6.
Heesen C, Bohm J, Reich C, Kasper J, Goebel M, Gold SM, Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable, Mult Scler 14 (2008), 988-91.
Sutliff MH, Contribution of impaired mobility to patient burden in multiple sclerosis, Curr Med Res Opin (2009)
Kurtzke JF, Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology 33 (1983), 1444-52.
Kalron A, Dvir Z, Achiron A, Walking while talking-difficulties incurred during the initial stages of multiple sclerosis disease process, Gait Posture 32 (2010), 332-5.
Martin CL, Phillips BA, Kilpatrick TJ, Butzkueven H, Tubridy N, McDonald E, Galea MP, Gait and balance impairment in early multiple sclerosis in the absence of clinical disability, Mult Scler 12 (2006), 620-8.
Corradini ML, Fioretti S, Leo T, Piperno R, Early recognition of postural disorders in multiple sclerosis through movement analysis: a modeling study, IEEE Trans Biomed Eng 44 (1997), 1029-38.
Sacco R, Bussman R, Oesch P, Kesselring J, Beer S, Assessment of gait parameters and fatigue in MS patients during inpatient rehabilitation: a pilot trial, J Neurol 258(5) (May 2011), 889-94. Epub 2010 Nov 15.
Goodman AD, Brown TR, Edwards KR, Krupp LB, Schapiro RT, Cohen R, Marinucci LN, Blight AR, A phase 3 trial of extended release oral dalfampridine in multiple sclerosis, Ann Neurol 68 (2010), 494-502.
Belachew S, Phan-Ba R, Bartholoḿe E, Delvaux V, Hansen I, Calay P, Hafsi KE, Moonen G, Tshibanda L, Vokaer M, Natalizumab induces a rapid improvement of disability status and ambulation after failure of previous therapy in relapsingremitting multiple sclerosis, Eur J Neurol 18(2) (Feb 2011), 240-5. doi: 10.1111/j.1468-1331.2010.03112.x.
Creange A, Serre I, Levasseur M, AudryD,Nineb A, Boerio D, Moreau T, Maison P, Walking capacities in multiple sclerosis measured by global positioning system odometer, Mult Scler 13 (2007), 220-3.
Gijbels D, Alders G, Van Hoof E, Charlier C, Roelants M, Broekmans T,Op 't Eijnde B, Feys P, Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures, Mult Scler 16 (2010), 618-26.
Givon U, Zeilig G, Achiron A, Gait analysis in multiple sclerosis: characterization of temporal-spatial parameters using GAITRite functional ambulation system, Gait Posture 29 (2009), 138-42.
Phan-Ba R, Pace A, Calay P, Grodent P, Douchamps F, Hyde R, Hotermans C, Delvaux V, Hansen I, Moonen G, Belachew S, Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis, Neurorehabil Neural Repair 25 (2011), 672-9.
Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, Syndulko K,Weinshenker BG, Antel JP, Confavreux C, Ellison GW, Lublin F, Miller AE, Rao SM, Reingold S, Thompson A,Willoughby E, Development of a multiple sclerosis functional composite as a clinical trial outcome measure, Brain 122 (Pt 5) (1999), 871-82.
Fischer JS, Rudick RA, Cutter GR, Reingold SC, The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force, Mult Scler 5 (1999), 244-50.
Phan-Ba R, Pace A, Calay P, Grodent P, Douchamps F, Hyde R, Hotermans C, Delvaux V, Hansen I, Moonen G, Belachew S, Comparison of the Timed 25-Foot and the 100-Meter Walk as Performance Measures in Multiple Sclerosis, Neurorehabil Neural Repair (2011).
Graham JE, Ostir GV, Fisher SR, Ottenbacher KJ, Assessing walking speed in clinical research: a systematic review, J Eval Clin Pract 14 (2008), 552-62.
Graham JE, Ostir GV, Kuo YF, Fisher SR, Ottenbacher KJ, Relationship between test methodology and mean velocity in timed walk tests: a review, Arch Phys Med Rehabil 89 (2008), 865-72.
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD,Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS, Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria, Ann Neurol 69 (2011), 292-302.
Hamilton F, Rochester L, Paul L, Rafferty D, O'Leary CP, Evans JJ, Walking and talking: an investigation of cognitivemotor dual tasking in multiple sclerosis, Mult Scler 15(10) (Oct 2009), 1215-27. Epub 2009 Aug 10.
Schulz D, Kopp B, Kunkel A, Faiss JH, Cognition in the early stage of multiple sclerosis, J Neurol 253 (2006), 1002-10.
Potagas C, Giogkaraki E, Koutsis G, Mandellos D, Tsirempolou E, Sfagos C, Vassilopoulos D, Cognitive impairment in different MS subtypes and clinically isolated syndromes, J Neurol Sci 267 (2008), 100-6.
Phan-Ba R, Calay P, Grodent P, Delrue G, Nagels G, Belachew S.Walking endurance assessment by a deceleration index calculated from performances on short and long distance walking tests in multiple sclerosis. American Academy of Neurology 63rd Annual Meeting. Hawä? Convention Center, Honolulu, Hawä? 2011.
Schwid SR, Thornton CA, Pandya S, Manzur KL, Sanjak M, Petrie MD, McDermott MP, Goodman AD, Quantitative assessment of motor fatigue and strength inMS, Neurology 53 (1999), 743-50.
